ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,508Medicare Part D Prescriptions Filled, Including Refills

Rank: 505 out of 1121

$331K Total Retail Price of All Prescriptions

Rank: 618 out of 1121

502 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 502 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 6,924 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SIMVASTATIN 379 348 1 1
OMEPRAZOLE 372 338 2 6
PRAVASTATIN SODIUM 322 305 3 14
AMLODIPINE BESYLATE 303 269 4 5
LEVOTHYROXINE SODIUM 274 243 5 2
LISINOPRIL 232 202 6 4
ZOLPIDEM TARTRATE 230 191 7 19
METFORMIN HCL ER 182 161 8 47
HYDROCHLOROTHIAZIDE 161 159 9 10
METOPROLOL TARTRATE 151 139 10 9
GABAPENTIN 138 123 11 13
TRIAMTERENE-HCTZ 137 123 12 38
ALLOPURINOL 131 116 13 30
CITALOPRAM HBR 129 111 14 18
DOXAZOSIN MESYLATE 129 129 14 93
INDAPAMIDE 121 121 16 138
TRAMADOL HCL 118 108 17 25
POTASSIUM CHLORIDE 113 81 18 12
LOSARTAN POTASSIUM 106 99 19 17
FUROSEMIDE 104 101 20 7
ENALAPRIL MALEATE 104 82 20 73
LISINOPRIL-HYDROCHLOROTHIAZIDE 101 101 22 31
WARFARIN SODIUM 97 83 23 11
ATORVASTATIN CALCIUM 93 93 24 15
METOPROLOL SUCCINATE 87 85 25 23
LOSARTAN-HYDROCHLOROTHIAZIDE 83 69 26 46
ENALAPRIL-HYDROCHLOROTHIAZIDE 83 81 26 296
FINASTERIDE 79 79 28 117
HYDROCODONE-ACETAMINOPHEN 76 73 S3 29 3
DIOVAN 67 67 30 45
KLOR-CON M20 60 58 31 85
ATENOLOL 57 54 32 16
CARVEDILOL 54 49 33 20
GLIPIZIDE 53 53 34 84
ALENDRONATE SODIUM 53 53 34 37
LOVASTATIN 53 53 34 26
SERTRALINE HCL 51 49 37 21
PROPRANOLOL HCL 51 51 37 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.